AI assistant
Sending…
Lineage Cell Therapeutics Inc. — Director's Dealing 2012
Jul 31, 2012
6895_dirs_2012-07-31_7b68fa01-1071-490c-a049-f72b7119a0f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2012-07-30
Reporting Person: GREENBELT CORP /NY (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-01 | Common Shares, no par value | G | 2000 | — | Disposed | 1968505 | Direct |
Footnotes
F1: During June 2012, Greenbelt Corp. gifted 2,000 common shares.
More from Lineage Cell Therapeutics Inc.
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Report Publication Announcement
2026
May 13
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Report Publication Announcement
2026
May 5
Earnings Release
2026
May 5
Investor Presentation
2026
May 4